Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-20 @ 9:47 PM
Study NCT ID:
NCT02916056
Status:
TERMINATED
Last Update Posted:
2021-06-01
First Post:
2016-08-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
Sponsor:
vTv Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-10
First Submit QC Date:
None
Study First Post Date:
2016-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-05-05
Results First Submit QC Date:
None
Results First Post Date:
2021-06-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-05-17
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-28
Last Update Post Date:
2021-06-01
Last Update Post Date Type:
ACTUAL